Tech Company Financing Transactions
Retrotope Funding Round
Private investors participated in a $4.6 million capital raise for Retrotope. This venture round was announced on 3/25/2016.
Transaction Overview
Company Name
Announced On
3/25/2016
Transaction Type
Venture Equity
Amount
$4,576,956
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 66 investors participated in the offering as amended. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4300 El Camino Real 201
Los Altos, CA 94022
USA
Los Altos, CA 94022
USA
Phone
Undisclosed
Website
Email Address
Overview
Retrotrope is striving to change aging as we know it, so that people do not have to suffer the ravages of many degenerative diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Marketing Officer
Peter Milner
Chief Scientific Officer
Mikhail Shchepinov
President
Anil Kumar
Vice President
Karsten Schmidt
VP - Bus. Development
Vidhya Gopalakrishnan
VP - Operations
Frederic Heerinckx
Browse more venture capital transactions:
Prev: 3/25/2016: Bromium venture capital transaction
Next: 3/25/2016: Fixt venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs